2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
DB03104ExperimentalSmall molecule
2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid: Overview.
![Chemical structure of 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid](/structures/DB03104/thumb.svg)
- Mechanism
- Curator reviewed
Pharmacologically active on Proto-oncogene tyrosine-protein kinase Src
- Formula / weight
- C33H33N3O6 · 567.6316 g/mol (avg)
- Code names
- RU82129
Resolves to
Compound
Structure
InChIKey
NKMPOVPTYDXGEC-MNRBYUMSSA-NSMILESCC(=O)N\C(=C/C1=CC=C(CC(O)=O)C(C=O)=C1)C(=O)N[C@H]1CCCCN(CC2=CC=C(C=C2)C2=CC=CC=C2)C1=OTargets
What you can answer from here — as of August 31, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account